Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects

被引:19
|
作者
Ahmed, Radwan H. [1 ]
Huri, Hasniza Zaman [2 ,3 ]
Al-Hamodi, Zaid [4 ]
Salem, Sameer D. [4 ]
Al-absi, Boshra [1 ]
Muniandy, Sekaran [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia
[3] Univ Malaya Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia
[4] Sanaa Univ, Dept Biochem & Mol Biol, Fac Med, Sanaa, Yemen
来源
PLOS ONE | 2016年 / 11卷 / 04期
关键词
DIPEPTIDYL-PEPTIDASE-IV; APOLIPOPROTEIN-B; INSULIN-RESISTANCE; RISK-FACTORS; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; LINKING OBESITY; DISEASE; INFLAMMATION; INHIBITOR;
D O I
10.1371/journal.pone.0154369
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Genetic polymorphisms of the Dipeptidyl Peptidase 4 (DPP4) gene may play a role in the etiology of type 2 diabetes mellitus (T2DM). This study aimed to investigate the possible association of single nucleotide polymorphisms (SNPs) of the DPP4 gene in Malaysian subjects with T2DM and evaluated whether they had an effect on the serum levels of soluble dipeptidyl peptidase 4 (sDPP-IV). Method Ten DPP4 SNPs were genotyped by TaqMan genotyping assays in 314 subjects with T2DM and 235 controls. Of these, 71 metabolic syndrome (MetS) subjects were excluded from subsequent analysis. The odds ratios (ORs) and their 95% confidence interval (CIs) were calculated using multiple logistic regression for the association between the SNPs of DPP4 and T2DM. In addition, the serum levels of sDPP-IV were investigated to evaluate the association of the SNPs of DPP4 with the sDPP-IV levels. Results Dominant, recessive, and additive genetic models were employed to test the association of DPP4 polymorphisms with T2DM, after adjusting for age, race, gender and BMI. The rs12617656 was associated with T2DM in Malaysian subjects in the recessive genetic model (OR = 1.98, p = 0.006), dominant model (OR = 1.95, p = 0.008), and additive model (OR = 1.63, p = 0.001). This association was more pronounced among Malaysian Indians, recessive (OR = 3.21, p = 0.019), dominant OR = 3.72, p = 0.003) and additive model (OR = 2.29, p = 0.0009). The additive genetic model showed that DPP4 rs4664443 and rs7633162 polymorphisms were associated with T2DM (OR = 1.53, p = 0.039), and (OR = 1.42, p = 0.020), respectively. In addition, the rs4664443 G>A polymorphism was associated with increased sDPP-IV levels (p = 0.042) in T2DM subjects. Conclusions DPP4 polymorphisms were associated with T2DM in Malaysian subjects, and linked to variations in sDPP-IV levels. In addition, these associations were more pronounced among Malaysian Indian subjects.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes
    Kim, Tae Hun
    Lee, Kiyoung
    Park, Ie Byung
    Choi, Cheol Soo
    Ahn, Tae Hoon
    Lee, Dae Ho
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 156
  • [42] Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review
    Vedantham, Srinivasan
    Kluever, Anna-Kristina
    Deindl, Elisabeth
    CELLS, 2018, 7 (10)
  • [43] Association of interleukin-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus
    Ho, Kuo-Ting
    Shiau, Ming-Yuh
    Chang, Yih-Hsin
    Chen, Chuan-Mu
    Yang, Shun-Chun
    Huang, Chien-Ning
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (12): : 1717 - 1722
  • [44] DPP-4 inhibitor approved for the treatment of type 2 diabetes mellitus
    不详
    FORMULARY, 2009, 44 (09) : 261 - 261
  • [45] Significant association between eNOS polymorphisms and type 2 diabetes mellitus
    Piatti, P
    Barlassina, C
    Casari, G
    Valsecchi, G
    Citterio, L
    Setola, E
    Galluccio, E
    Pozza, G
    Monti, LD
    DIABETES, 2002, 51 : A268 - A268
  • [46] Association study between LXRβ polymorphisms and type 2 diabetes mellitus
    Solaas, K.
    Legry, V.
    Holven, K. B.
    Retterstol, K.
    Thorsby, P. M.
    Ferrieres, J.
    Tonstad, S.
    Rootwelt, H.
    Lien, S.
    Halvorsen, B.
    Nenseter, M. S.
    Amouyel, P.
    Birkeland, K.
    Meirhaeghe, A.
    Nebb, H. I.
    DIABETOLOGIA, 2009, 52 : S138 - S138
  • [47] Association of APOE and CETP TaqIB Polymorphisms with Type 2 Diabetes Mellitus
    Srirojnopkun, Chatinun
    Kietrungwilaikul, Kridtaporn
    Boonsong, Katesaraphorn
    Thongpoonkaew, Jetnarong
    Jeenduang, Nutjaree
    ARCHIVES OF MEDICAL RESEARCH, 2018, 49 (07) : 479 - 485
  • [48] Sitagliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Johnson, Kathryn M. S.
    Schurr, Kathleen
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 81 - 92
  • [49] Association of Toll-like Receptor 4Gene polymorphisms with susceptibility to type 2 diabetes mellitus in the Chinese population
    Peng, Danfeng
    Jiang, Feng
    Zhang, Rong
    Tang, Shanshan
    Chen, Miao
    Yan, Jing
    Sun, Xue
    Luo, Yi
    Hu, Cheng
    Jia, Weiping
    JOURNAL OF DIABETES, 2015, 7 (04) : 485 - 492
  • [50] T-Cell DPP4 Expression Is Related With Metabolic Control and Serum Interleukin-2 Level in Patients With Type 2 Diabetes Mellitus
    Jo, Jaemin
    Kim, Young Ree
    Lee, Sang Ah
    Koh, Gwanpyo
    Lee, Dae Ho
    DIABETES, 2013, 62 : A439 - A439